REQUEST A DEMO
Total
USD $0.00
Search more companies

Comerlat Pharmaceutical S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Securities and Commodity Exchanges
Full name: Comerlat Pharmaceutical S.A.S. Profile Updated: October 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Comerlat Pharmaceutical S.A.S. is based in Colombia, with the head office in Cali. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Comerlat Pharmaceutical S.A.S. was incorporated on January 18, 2007. It currently has a total number of 12 (2024) employees. The latest financial highlights indicate a net sales revenue drop of 10.23% in 2024. Its’ total assets recorded a negative growth of 14.43%. In 2024, Comerlat Pharmaceutical S.A.S.’s net profit margin decreased by 13.85%.

Headquarters
Cr 7 D # 70-131
Cali; Valle del Cauca;

Contact Details: Purchase the Comerlat Pharmaceutical S.A.S. report to view the information.

Website: http://www.comerlatpharmasa.com

Basic Information
Total Employees:
Purchase the Comerlat Pharmaceutical S.A.S. report to view the information.
Registered Capital:
Purchase the Comerlat Pharmaceutical S.A.S. report to view the information.
Financial Auditors:
Purchase the Comerlat Pharmaceutical S.A.S. report to view the information.
Incorporation Date:
January 18, 2007
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
41%
Purchase this report to view the information.
36%
Purchase this report to view the information.
10%
Purchase this report to view the information.
8%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Comerlat Pharmaceutical S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-10.23%
Total operating revenue
-10.55%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-58565.82%
Total assets
-14.43%
Total equity
-33.56%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-13.85%
Return on Equity (ROE)
-50.46%
Debt to Equity Ratio
3.24%
Quick Ratio
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?